Acute effects of lysergic acid diethylamide (LSD) on resting brain function.
Müller, F., & Borgwardt, S. | Swiss Medical Weekly | 30 September 2019
The psychedelic renaissance: the next trip for psychiatry?
Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C., & O’Keane, V. | Irish journal of psychological medicine | 23 September 2019
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019
Hallucinogens and Their Therapeutic Use: A Literature Review
BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019
Harnessing Neuroimaging to Enhance Our Understanding of the Effects of Ketamine in Depression.
Jaworska, N., & Phillips, J. L. | Cognitive neuroscience and neuroimaging | 1 July 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 1 July 2019